XYL Xylem Inc.
Pumps & Pumping Equipment · NYSE · SEC CIK 1524472 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.9%
TTM net income YoY14.1%
TTM EPS YoY16.2%
Revenue 3-yr CAGR10.3%
Net income 3-yr CAGR30.0%
Margins
Gross margin39.8%
Operating margin15.1%
Net margin11.9%
FCF margin10.2%
EBITDA margin21.3%
Returns
ROE10.1%
ROA6.3%
ROIC (approx.)9.0%
Asset turnover0.52x
Leverage & solvency
Liabilities / assets39.3%
Debt / equity0.28x
Current ratio1.39x
Interest coverage36.11x
Cash quality & payout
Operating cash flow / net income1.18x
Accruals ratio-1.1%
Payout ratio37.4%
Capex / revenue3.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2.20B | $2.34B | $2.12B | $2.40B | $2.27B | $2.30B | $2.07B | $2.26B |
| Cost of revenue | $1.29B | $1.37B | $1.32B | $1.47B | $1.39B | $1.41B | $1.30B | $1.40B |
| Gross profit | $907.00M | $963.00M | $803.00M | $932.00M | $883.00M | $892.00M | $768.00M | $857.00M |
| R&D expense | $56.00M | $59.00M | $56.00M | $60.00M | $52.00M | $58.00M | $56.00M | $58.00M |
| SG&A expense | $458.00M | $503.00M | $472.00M | $486.00M | $474.00M | $503.00M | $460.00M | $507.00M |
| Operating income | $385.00M | $390.00M | $244.00M | $353.00M | $334.00M | $305.00M | $231.00M | $267.00M |
| Interest expense | $21.00M | $7.00M | $4.00M | $6.00M | $6.00M | $9.00M | $8.00M | $9.00M |
| Pretax income | $365.00M | $364.00M | $244.00M | $368.00M | $297.00M | $299.00M | $217.00M | $375.00M |
| Income tax | $77.00M | $103.00M | $55.00M | $35.00M | $71.00M | $75.00M | $50.00M | $49.00M |
| Net income | $291.00M | $263.00M | $193.00M | $335.00M | $227.00M | $226.00M | $169.00M | $326.00M |
| EBITDA | $672.00M | $455.00M | $309.00M | $496.00M | $398.00M | $374.00M | $299.00M | $638.00M |
| EPS (basic) | 1.25 | 1.11 | 0.79 | — | 0.93 | 0.93 | 0.69 | — |
| EPS (diluted) | 1.25 | 1.11 | 0.79 | — | 0.93 | 0.93 | 0.69 | — |
| Dividends declared per share | 0.43 | 0.43 | 0.43 | 0.40 | 0.40 | 0.40 | 0.40 | 0.36 |
| Weighted avg. shares (diluted) | 233.04M | 236.57M | 243.36M | — | 244.09M | 243.86M | 243.78M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $708.00M | $1.28B | $808.00M | $1.48B | $1.19B | $1.17B | $1.06B | $1.12B |
| Receivables | $1.97B | $1.88B | $1.80B | $1.76B | $1.80B | $1.84B | $1.74B | $1.67B |
| Inventory | $1.05B | $1.02B | $991.00M | $983.00M | $1.03B | $1.07B | $1.02B | $996.00M |
| Current assets | $3.95B | $4.39B | $4.03B | $4.64B | $4.44B | $4.37B | $4.08B | $4.10B |
| PP&E, net | $1.20B | $1.17B | $1.15B | $1.16B | $1.14B | $1.19B | $1.16B | $1.15B |
| Goodwill | $8.52B | $8.26B | $8.29B | $8.33B | $8.28B | $8.24B | $8.06B | $7.98B |
| Intangibles | $2.22B | $2.15B | $2.21B | $2.27B | $2.32B | $2.35B | $2.33B | $2.38B |
| Total assets | $17.33B | $17.34B | $16.95B | $17.63B | $17.30B | $17.19B | $16.56B | $16.49B |
| Current liabilities | $2.84B | $2.72B | $2.75B | $2.86B | $2.27B | $2.30B | $2.17B | $2.34B |
| Short-term debt | $530.00M | $531.00M | $531.00M | $534.00M | $49.00M | $68.00M | $41.00M | $38.00M |
| Long-term debt | $2.37B | $2.40B | $1.41B | $1.41B | $1.91B | $1.93B | $1.97B | $1.98B |
| Total debt | $2.90B | $2.93B | $1.94B | $1.94B | $1.96B | $2.00B | $2.02B | $2.02B |
| Total liabilities | $6.82B | $6.68B | $5.72B | $5.88B | $5.85B | $5.88B | $5.50B | $5.61B |
| Shareholders' equity | $10.27B | $10.42B | $10.97B | $11.48B | $11.21B | $11.07B | $10.82B | $10.64B |
| Net debt | $2.19B | $1.65B | $1.13B | $463.00M | $771.00M | $826.00M | $956.00M | $895.00M |
| Shares outstanding | — | — | — | 243.58M | — | — | — | 242.99M |
| Cash flow statement | ||||||||
| Operating cash flow | $331.00M | $290.00M | $108.00M | $543.00M | $360.00M | $305.00M | $33.00M | $575.00M |
| Capital expenditure | $89.00M | $89.00M | $90.00M | $83.00M | $79.00M | $98.00M | $71.00M | $100.00M |
| Free cash flow | $242.00M | $201.00M | $18.00M | $460.00M | $281.00M | $207.00M | -$38.00M | $475.00M |
| Investing cash flow | -$456.00M | -$22.00M | -$76.00M | -$142.00M | -$189.00M | -$125.00M | -$15.00M | -$289.00M |
| Financing cash flow | -$451.00M | $199.00M | -$683.00M | -$119.00M | -$138.00M | -$128.00M | -$116.00M | -$95.00M |
| Depreciation & amortization | $287.00M | $65.00M | $65.00M | $143.00M | $64.00M | $69.00M | $68.00M | $371.00M |
| Stock-based compensation | $14.00M | $12.00M | $13.00M | $16.00M | $12.00M | $13.00M | $12.00M | $13.00M |
| Dividends paid | $100.00M | $101.00M | $106.00M | $98.00M | $97.00M | $98.00M | $98.00M | $87.00M |
| Share buybacks | $337.00M | $680.00M | $563.00M | $1.00M | $1.00M | $0 | $13.00M | $1.00M |
Free plan shows the latest 8 periods; Pro shows all 65 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.